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Graz, AustriaABSTRACT We previously developed a single-molecule microscopy method termed TOCCSL (thinning out clusters while
conserving stoichiometry of labeling), which allows for direct imaging of stable nanoscopic platforms with raft-like properties
diffusing in the plasma membrane. As a consensus raft marker, we chose monomeric GFP linked via a glycosylphosphatidyl-
inositol (GPI) anchor to the cell membrane (mGFP-GPI). With this probe, we previously observed cholesterol-dependent
homo-association to nanoplatforms diffusing in the plasma membrane of live CHO cells. Here, we report the release of this
homo-association upon addition of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) or 1-palmitoyl-2-glutar-
oyl-sn-glycero-3-phosphocholine, twooxidizedphospholipids (oxPLs) that are typically present in oxidativelymodified low-density
lipoprotein. We found a dose-response relationship for mGFP-GPI nanoplatform disintegration upon addition of POVPC, corre-
lating with the signal of the apoptosis marker Annexin V-Cy3. Similar concentrations of lysolipid showed no effect, indicating
that the observed phenomena were not linked to properties of the lipid bilayer itself. Inhibition of acid sphingomyelinase by NB-
19 before addition of POVPC completely abolished nanoplatform disintegration by oxPLs. In conclusion, we were able to deter-
mine how oxidized lipid species disrupt mGFP-GPI nanoplatforms in the plasma membrane. Our results favor an indirect mech-
anism involving acid sphingomyelinase activity rather than a direct interaction of oxPLs with nanoplatform constituents.INTRODUCTIONPolyunsaturated fatty acids esterified to phospholipids are
frequently modified by reactive oxygen species, resulting in
biologically active oxidized phospholipids (oxPLs) (1,2).
The resulting oxPL stress affects the chemical structures
of biomolecules and, as a consequence, signaling cascades
triggering pathophysiological effects in the cells of the
vascular wall (3). Inflammatory diseases involving oxPLs
include neurodegenerative processes, type 2 diabetes, age-
relatedmacular degeneration, and cancer (reviewed inKinnu-
nen et al. (4)). Most importantly, the formation of oxidized
low-density lipoprotein (LDL) due to modification of
its (phospho)lipid and protein constituents is a hallmark of
the development of atherosclerosis (reviewed in Stemmer
andHermetter (2)). Apoptosis of vascular cells is a prominent
feature of the late phase of the chronic disease atherosclerosis,
which leads to plaque rupture followed by acute vascular
events (5,6). We previously showed that both 1-palmitoyl-
2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC),
an oxPL carrying an aldehyde group at the truncated
chain, and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phospho-Submitted August 25, 2015, and accepted for publication November 13,
2015.
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0006-3495/16/01/0205/9choline (PGPC), an oxPL carrying a carboxylic group, can
induce apoptosis in cultured vascular smooth muscle cells
and macrophages (7,8). This phenomenon is causally linked
to the fast activation of an acid sphingomyelinase (aSMase),
which subsequently generates ceramide, an apoptotic second
messenger in these cells (7,8). However, the molecular mech-
anism of oxPL sensing in the plasma membrane and the
consecutive structural changes of the membrane-associated
components have remained enigmatic.
We recently found that properties of the plasma mem-
brane of living cells can be altered by incorporating oxPL
species containing a carboxy residue at the truncated sn-2
chain. PGPC-treated cells showed significantly increased
mobility of a tracer lipid, reflecting a PGPC-induced
change of the cell membrane viscosity, and dramatic
morphological changes within 30 s of treatment (9). Studies
on model membranes have shown how oxPLs affect the
basic biophysical properties of the host membrane (for a
review see Jurkiewicz et al. (10)). The increased lateral
diffusion and local mobility of lipids upon addition of
various oxPL species could be linked to the orientation of
the oxidized lipid chain in the aqueous solution (11). In
turn, single-molecule-tracking experiments suggested that
diffusion of the fluorescently labeled lipid 1-palmitoyl-2-
glutaroyl-sn-glycero-3-phospho-N-Alexa647-ethanolamine
(PGPE-A647) was twice as high as that of a non-oxPL athttp://dx.doi.org/10.1016/j.bpj.2015.11.018
206 Brameshuber et al.37C in a supported lipid bilayer (12). Interestingly, the dif-
ference in mobility was reduced by increasing the choles-
terol concentration in the lipid bilayer. Based on
molecular-dynamics (MD) simulations, investigators
ascribed this effect to an increased interaction of oxPLs
with the lipid matrix at high cholesterol levels, thereby pull-
ing the oxPL headgroup closer to the bilayer interface. In
addition, recent MD simulation and dynamic light-scat-
tering experiments showed colocalization of cholesterol
and oxPL in lipid bilayers (13). Also, Stefl and co-workers
(14) found cholesterol rearrangement and preferred interac-
tions with carbonyls of PGPC chains in oxidized model
membranes. Micrometer-sized sphingomyelin/cholesterol
domains were found to be stabilized in monolayers of
ternary lipid mixtures by oxPLs containing an aldehyde or
a carboxylic group at the truncated chain (15). It should
be noted that the aldehyde derivative was more efficient at
stabilizing phase separation, possibly due to the different
orientation of the oxidatively truncated acyl chains (16)
and therefore an enhanced interaction of the aldehyde deriv-
ative with sphingomyelin (15). Additionally, oxPLs with an
aldehyde group at the sn-2 position proved to be more cyto-
toxic than those with the carboxylic group (17), probably
because of the ability of the aldehyde group to covalently
interact with primary amino groups of proteins and amino
phospholipids via the formation of Schiff bases (3).
In this work, we aimed to understand the effects of oxPL
treatment on the live-cell plasma membrane of Chinese
hamster ovary (CHO) cells on the nanoscopic level. Recent
advances in imaging techniques have allowed the detection
of signaling platforms in the membrane based on their
ability to accommodate glycosylphosphatidylinositol (GPI)-
anchored proteins (18–22). These nanoplatforms seem to in-
fluence signal transduction (23–27), and their disruption can
cause signal abrogation or initiation (28,29). At this time,
however, it is unclear to what extent the different protein
and lipid domains identified in the plasma membrane relate
to the concept of a lipid-driven phase separation mediating
the formation of more or less stable protein associates, which
was the basis for the lipid raft hypothesis (30) (for a discus-
sion, see Klotzsch and Schu¨tz (31)). In fact, a recent study
from our lab challenged the view that ordered-phase forma-
tion drives the association of GPI-anchored proteins (32).
Using single-molecule microscopy, we previously de-
tected the presence of stable but mobile homo-associates
of a model GPI-anchored protein and of another putative
raft marker (Bodipy-GM1) diffusing in the plasma mem-
brane of different cell lines (20). In line with other studies
(33–36), we chose a minimal GPI-anchored protein, mono-
meric GFP anchored via GPI to the plasma membrane
(mGFP-GPI), which was shown to probe basic membrane
properties similar to those probed by its counterparts con-
taining a fully functional extracellular domain (33,34,37).
In our previous study (20), we found that ~20–50% of the
mGFP-GPIs examined were present as homodimers, whichBiophysical Journal 110(1) 205–213is in line with other fluorescence microscopy approaches
that showed a nonhomogeneous plasma membrane distribu-
tion of mGFP-GPI on the nanoscale (19,22,33–35,37). Inter-
estingly, cholesterol depletion resulted in a complete
disintegration of the observed homo-dimers, indicating
that the local lipid environment is a crucial factor for the
cohesion of mGFP-GPI assemblies. We termed these
cholesterol-dependent mGFP-GPIs homodimer nanoplat-
forms. Thus, it appeared attractive to hypothesize that mo-
lecular interactions between cholesterol and oxPL could
also occur in the native plasma membrane and account (at
least partly) for oxPL’s modes of action.
In this work, we studied the effect of oxPLs on plasma
membrane nanoplatforms using single-molecule micro-
scopy. We observed the disintegration of mGFP-GPI nano-
platforms upon addition of PGPC or POVPC. Interestingly,
treatment with lysolipids had no effect, ruling out a general
alteration of lipid bilayer properties due to the addition of in-
verted-cone-shaped lipids. The loss of mGFP-GPI homo-as-
sociation upon POVPC addition correlated with apoptosis
signals observed by detecting the amount of phosphatidylser-
ine (PS) in the outer leaflet of the plasma membrane.MATERIALS AND METHODS
Fusion constructs and cell culture
An mGFP-GPI plasmid carrying the GPI signal sequence of the human
folate receptor was constructed as described previously (20). Briefly, the
GFP in the GPI-GFP pJB20 plasmid (a kind gift from Jennifer Lippin-
cott-Schwartz) was mutated at amino acid position 206 from alanine to
lysine to obtain a monomeric GFP (mGFP) variant (38). CHO cells
(ATTC CCL-61) stably transfected with mGFP-GPI were grown in
DMEM/HAM’s F-12 medium (BE12-719F; Lonza, Switzerland) supple-
mented with 10% fetal calf serum (F7524; Sigma-Aldrich, St. Louis,
MO), 400 mg/mL G418 (P11-012; PAA, Linz Austria), and 100 U/mL peni-
cillin/streptomycin (17-602E; Lonza). Cells were cultured in a humidified
atmosphere at 37C and 5% CO2 on 10 cm tissue culture plates (64 160;
Greiner Bio-One, Kremsmu¨nster, Austria).Sample preparation
Coverglass slides (#1.5, BB024060SC; Menzel, Braunschweig, Germany)
were glued to eight-well Lab-Tek chambers (155411, Nunc; Thermo Fisher
Scientific, Waltham, MA) with the use of two-component dental glue
(13001001; Picodent, Germany) and washed with 70% isopropanol and
sterile water. Confluent CHO cells were harvested using Accutase (00-
4555-6; eBioscience, San Diego, CA) and seeded into Lab-Tek chambers
at least 24 h before experiments were conducted. Before treatments, cells
were washed twice in a 37C Hanks’ buffered salt solution (HBSS) contain-
ing calcium and magnesium (BE10-527F; Lonza). A stock solution of
5 mg/mL POVPC (870606P; Avanti Polar Lipids, Alabaster, AL) or
5 mg/mL PGPC (870602P; Avanti Polar Lipids) was prepared in ethanol
and injected into a defined volume of HBSS to reach the desired oxPL con-
centrations. Seeded and treated cells were incubated for 20 min at 37C
before microscopy or lipid extraction experiments were conducted. For
aSMase-inhibition experiments, the inhibitor NB-19 (9-(3-{4-[2-(4-me-
thoxy-phenyl)-ethyl]-3,5-dimethyl-piperazine-1-yl}-propyl)-9H-carbazol)
was dissolved in ethanol at a concentration of 5 mM. Cells were incubated
with 10 mM of NB-19 diluted in HBSS for 30 min at 37C, washed twice in
oxPL Disrupt mGFP-GPI Nanoplatforms 207HBSS, and incubated with oxPL as described above. For all experiments,
the final ethanol concentration did not exceed 1% (v/v) of total incubation
volume. This low amount of ethanol had no membrane-perturbing effects.
The presence of 0.2% v/v ethanol (NB-19) or 0.44% v/v ethanol (NB-19 þ
POVPC) did not lead to a detectable change of the dimer fraction
compared with nontreated cells (see Fig. 5 A). 1-Palmitoyl-2-hydroxy-
sn-glycero-3-phosphocholine (16:0 Lyso-PC, 855675; Avanti Polar Lipids)
was dissolved in ethanol at a final concentration of 10 mM and injected
into HBSS to reach the desired incubation concentrations.
For cholesterol-depletion experiments, cells were incubated with 2 U/mL
cholesterol oxidase (COase, C8649; Sigma-Aldrich) at 37C for 20 min.
The COase was not removed during the experiments. For aSMase-inhibi-
tion experiments, cells were preincubated with 5 mM of NB-19 for
30 min at 37C and washed twice in HBSS.Apoptosis assay
Cells were seeded into 96-well tissue culture plates (655 160; Greiner Bio-
One) 24 h before experiments. The cells were washed twice with 37C
HBSS and then treated with NB-19 and oxPL as described above. Apoptosis
was detected 30 or 90 min after oxPL incubation using the Annexin V-Cy3
kit (APOAC; Sigma-Aldrich). The kit was applied as described in the man-
ufacturer’s manual. Readout was performed using a plate reader (Synergy
H1; BioTek, Winooski, VT) with the appropriate excitation/emission set-
tings. For every condition, at least four wells were used and the mean fluo-
rescence was calculated.FIGURE 1 Experimental design for detecting nanoplatforms. (A–C) The
principle of the TOCCSL technique. (A) A living CHO cell stably express-
ing the probe mGFP-GPI. An excitation field stop is used to illuminate only
a part of the bottom cell membrane in TIR mode (dashed area). The overall
density of mGFP-GPI is too high to resolve individual mGFP-GPI nanoplat-
forms. The sketch displays a high density of nanoplatforms (black circles)
confining the marker mGFP-GPI. After an ~400-ms-long laser pulse, all
mGFP molecules within the observed area become irreversibly photo-
bleached. (B) The efficiency of photobleaching was controlled by recording
an image 1 ms after the bleach pulse. (C) After a recovery time of 1 s, the
first fluorescent spots entering the field of view can be observed as diffrac-
tion-limited signals. For display, the contrast in (B) and (C) was increased
by a factor of 5 compared with (A). The sketch shows an individual recov-
ered nanoplatform, which is now easily resolvable in the presence of
bleached mGFP-GPI. (D) The corresponding laser-intensity protocol. The
letters a–c indicate the laser pulses used to record the corresponding images
in (A)–(C), and d indicates the laser pulse used to record the image for deter-
mining the brightness distribution of individual GFPs, r1 (monomer distri-
bution). (E and F) The brightness distributions, rN , of single mGFP-GPI
spots before (E) and after (F) addition of 10 mMPOVPC are plotted as prob-
ability density functions. Data (black line) were fitted by Eq. 1 (red line).
Monomer (solid) and dimer (dashed) contributions are shown as blue lines.
The dimer fraction a2 was reduced from 30.8% 5 2.5% (n ¼ 6 cells) to
8.3%5 3.3% (n ¼ 6 cells) after addition of POVPC. Insets show the pu-
tative effect of oxPLs on mGFP-GPI nanoplatforms. All experiments
were performed at 37C. Scale bar: 2 mm.Microscopy
Single-molecule experiments were performed as described by Brameshuber
et al. (20). Briefly, a Zeiss Axiovert 200 microscope equipped with a 100
NA¼1.46 Plan-Apochromat (Zeiss, Oberkochen, Germany) was used to
excite cells in objective-based total internal reflection fluorescence (TIRF)
configuration via the epiport using 488 nm light from an optically pumped
semiconductor laser (Sapphire; Coherent, Santa Clara, CA). The power
was adjusted to 2–10 kW/cm2 on the sample. A slit aperture (Thorlabs,
Newton, NJ) with a width of ~7 mm in the object plane was used as the field
stop. For exact timings, an acousto-opticmodulator (Isomet, Springfield,VA)
was used. Timing protocols were generated and controlled by an in-house-
written programpackage implemented in LABVIEW (National Instruments,
Austin, TX). After the appropriate filtering (dichroic mirror: ZT488/640rpc
2 mm, Chroma, Bellows Falls, VT; emission filter: FF01-538/685-25, Sem-
rock, Rochester, NY), fluorescence images were recorded using a back-illu-
minated, nitrogen-cooled CCD camera (Roper Scientific Micro Max
1300-PB; PI Acton, Trenton, NJ). The temperature during experiments
was maintained at 37C by means of an in-house-built incubator box equip-
ped with a heating unit and an objective heater (PeCon, Erbach, Germany).
TOCCSL (thinning out clusters while conserving stoichiometry of label-
ing) (39) experiments were performed as described elsewhere (20). Briefly,
after recording a prebleach image with a power density of ~2 kW/cm2 and
an illumination time of till¼ 2 ms (Fig. 1, A and D, pulse a), the sample was
bleached for tbleach ¼ 400 ms with a 5-fold higher power density. After an
adjustable recovery time, trecover ¼ 0.5–3 s, up to 20 images with a typical
delay of 20 ms were recorded with same settings as used for the prebleach
image. To confirm that bleaching was complete, an optional experiment was
carried out with a recovery time of trecover¼ 1 ms (Fig. 1, B and D, pulse b).
Then the recovery time was increased to allow for the reentry of unbleached
mGFP-GPI molecules from the shielded region. The first recorded image
after the adjustable recovery time, trecover (Fig. 1, C and D, pulse c), was
used for brightness analysis (TOCCSL image), and the last image was
used to determine the single-molecule brightness of mGFP (Fig. 1 D, pulse
d). Due to the low bleach stability of GFP, the probability of observing more
than one active mGFP-GPI per diffraction-limited spot in the last image is
negligible (20). The sample sizes for all of the TOCCSL experiments areBiophysical Journal 110(1) 205–213
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one cell could be repeated 20–60 times because for every TOCCSL run,
only a small part of the bottom cell membrane was bleached. TOCCSL
runs were separated by a delay of 10 s. To control for photophysical effects
on membrane constituents due to the high power of the photobleaching
pulse, we compared the results of multiple sequential TOCCSL runs on
identical cells. We found no change in the mGFP-GPI dimer fraction
(Fig. S1). Thus, our data rule out the formation of photo-induced oxPL spe-
cies during the experiment, which would have led to a decreased dimer frac-
tion (compare with Figs. 2 and 4). In addition, in our previous study (20),
we performed control experiments to rule out potential photo-induced
cross-linking of mGFP-GPI in the same cell line, and discussed the results
in an extensive supplement.Data analysis
Analysis of TOCCSL recordings was performed as described previously
(20). Briefly, algorithms written in-house in MATLAB (The MathWorks,
Natick, MA) were used to detect and quantify individual diffraction-limited
signals. A maximum-likelihood estimator was used to determine the posi-
tion, integrated brightness B, full width at half-maximum, and local back-
ground of recovered mGFP-GPI signals. Brightness analysis was
performed as described previously (39,40). The brightness values of single
mGFP-GPI molecules pooled from all cells for one experimental condition
were used to calculate the probability density function r1ðBÞ of monomers.
Due to the stochastic emission process of photons, the corresponding prob-
ability density functions of N colocalized emitters can be calculated by a
series of convolution integrals, rNðBÞ ¼
R
r1ðB0ÞrN1ðB B0ÞdB0. A linear
combination of the resulting brightness distributions was used to calculate a
mixed population of monomers and higher-order multimers:
rðBÞ ¼
XNmax
N¼ 1
aNrNðBÞ: (1)
A minimum of 250–500 brightness values (41) from TOCCSL images of
one experimental condition were used to calculate rðBÞ. A least-squares fit
with Eq. 1 was used to determine the weights of the individual distributions,
aN , with
PNmax
N¼1aN ¼ 1. For all experiments, no higher contributions than
dimers ða2Þ were observed. For error-bar estimation, a random 50% sub-
sample of brightness values was drawn from all brightness values from
the TOCCSL images and used to calculate a2. This sampling was repeated
100 times, and the mean and standard deviation (SD) of a2 were calculated
and displayed as error bars. The source code for the MATLAB programs
used in this work can be found in the Supporting Material.FIGURE 2 Effect of oxPLs on mGFP-GPI nanoplatform integrity.
(A) CHO cells stably expressing mGFP-GPI were preincubated with the
indicated lipids for 20 min. TOCCSL experiments were carried out in the
presence of these lipids on a minimum of six cells for each condition.
The dimer fraction a2 decreased substantially upon exposure to the oxPLs
PGPC and POVPC. Mock treatment (contr) or incubation with lysolipid had
no effect on the integrity of mGFP-GPI nanoplatforms. (B) Structure of the
lipids used. All experiments were carried out at 37C.
Biophysical Journal 110(1) 205–213Lipid extraction and mass spectrometry analysis
A total of 700,000 cells were seeded 24 h before experiments began. After
treatment with 10 mM PGPC, 10 mM POVPC, or 10 mM Lyso-PC (as
described above), supernatants and cells were collected for subsequent lipid
extraction. Trypsinized cells were washed twice with HBSS and the super-
natant was completely removed after centrifugation at 4000 rpm for 10 min.
Lipids from both the cells and supernatants were extracted in the presence
of PC(40:0) as the extraction standard and quantitated by shotgun lipidomic
analysis on an LTQ-Orbitrap Elite instrument (Thermo Fisher Scientific,
Bremen, Germany) as described in Antal et al. (42).RESULTS
oxPL species cause disintegration of mGFP-GPI
nanoplatforms
We used TOCCSL, a variant of single-molecule microscopy
(20,39,41), to detect mGFP-GPI homo-association in the
live-cell plasma membrane. The principle of this approach
and its putative effect on membrane nanoplatforms are
outlined in Fig. 1, A–C. CHO cells stably expressing
mGFP-GPI were imaged at 37C with an epifluorescence
microscope in TIR mode. The high mGFP-GPI surface den-
sity of up to 1000 copies/mm2 does not allow for the direct
detection of mGFP-GPI nanoplatforms, as it results in a
rather homogeneous fluorescence distribution on the plasma
membrane caused by nanoplatforms spaced closer than the
resolution of optical microscopy (Fig. 1 A). By applying a
high-power laser pulse, we were able to completely photo-
bleach a spatially bounded area of the plasma membrane
(Fig. 1 B). After a recovery time of 800–2500 ms, we
observed a few diffraction-limited signals in the TOCCSL
image that had entered the field of view from unbleached
parts of the cell by Brownian motion (Fig. 1 C). The broad
distribution of the brightness values of signals detected in
the TOCCSL image is plotted as a probability density func-
tion, rðBÞ, in Fig. 1 E. We quantified the amount of mGFP-
GPI molecules per signal by comparison with the brightness
of a single mGFP molecule, which we determined in the
same experiment upon prolonged photobleaching. For quan-
tification, we fitted rðBÞ with a linear combination of n-mer
brightness distributions, rnðBÞ (Eq. 1), derived from the dis-
tribution of single mGFP molecules ðr1ðBÞÞ. The weights of
the fit ðanÞ correspond to the fraction of n-mers (see ‘‘Data
analysis’’ section in Materials and Methods). Consistent
with our previous study, we found a dimer fraction of
a2 ¼ 31% 5 3%, representing two mGFP-GPI molecules
stably associated to nanoplatforms (20).
To test the influence of oxPL on nanoplatforms, we incu-
bated mGFP-GPI expressing CHO cells with 10 mMPOVPC
(for the structure, see Fig. 2 B) 20 min before the TOCCSL
experiment. A pronounced shift of the brightness distribu-
tion, rðBÞ, toward the distribution of single mGFP-GPI sig-
nals was visible (Fig. 1 F). Quantification revealed a
reduction of the mGFP-GPI dimer fraction to 8% 5 3%,
i.e., more than 73% of all observed nanoplatforms had
FIGURE 3 Membrane insertion of oxPL and Lyso-PC. CHO cells stably
expressing mGFP-GPI were mock treated (HBSS) or incubated with 10 mM
Lyso-PC, 10 mM PGPC, or 10 mM POVPC for 20 min at 37C. After lipid
extraction, the lipids were quantitated by MS analysis. (A–C) MS quantita-
tion of Lyso-PC (A), PGPC (B), and POVPC (C). Data are presented as
means5 SD for three independent measurements.
oxPL Disrupt mGFP-GPI Nanoplatforms 209disintegrated (Fig. 2 A). The overall surface density of
mGFP-GPI was not significantly affected by the presence
of oxPL in the plasma membrane (nontreated cells:
389 5 83 molecules/mm2, POVPC-treated cells: 337 5
61 molecules/mm2).
To further study whether the observed disintegration of
mGFP-GPI nanoplatforms is a general effect of oxPLs, we
tested PGPC, a different oxPL that carries a carboxylic
acid instead of the aldehyde group at the sn-2 position (for
the structure, see Fig. 2 B). mGFP-GPI-expressing cells
were incubated with 10 mM PGPC 20 min before the
TOCCSL experiment and brightness analysis was per-
formed as described above. We found that the mGFP-GPI
nanoplatform fraction was reduced to 6% 5 2%, which is
comparable to the decrease observed for POVPC (Fig. 2
A). Mock treatment of cells showed no effect.
There are two structural features of oxPL that could be
responsible for nanoplatform disintegration: 1) the oxidized
fatty acid at the sn-2 position, which carries either an alde-
hyde (POVPC) or a carboxyl (PGPC) group, or 2) the remain-
ing saturated fatty acid at the sn-1 position, which bestows an
inverse-cone shape to the lipid (9) in contrast to the non-
oxPL. To test whether the observed effects were a direct
consequence of this geometrical feature of the lipids (e.g.,
mediated by a change in the pressure profile of themembrane
upon integration of noncylindrical lipids), we repeated the
experiments using Lyso-PC, a similarly inverted cone-
shaped lipid. Lipid mass spectrometry (MS) revealed even
higher membrane insertion of Lyso-PC compared with the
oxPL probes (Fig. 3). Brightness analysis, however, yielded
an unchanged mGFP-GPI dimer fraction of 38% 5 2%
(10 mM Lyso-PC) and 36% 5 3% (20 mM Lyso-PC)
(Fig. 2 A). Apparently, the shape of the added lipids is not
responsible for nanoplatform disintegration, so we shifted
our focus to a potential functional role of the oxidized sn-2
acyl residue in disintegration of mGFP-GPI nanoplatforms.POVPC-induced mGFP-GPI nanoplatform
disintegration correlates with apoptosis
We next examined the dimer fraction with respect to the
applied POVPC concentration. For each individual POVPC
concentration, we performed a TOCCSL experiment on
mGFP-GPI-expressing cells, and the dimer fraction was
determined via brightness analysis as described above. We
observed the strongest change for POVPC concentrations
between 0 and 10 mM (Fig. 4 A). For higher concentrations,
the dimer fraction did not decrease further; however,
morphological changes of the cells were more pronounced
and experiments were limited to a duration of 1 h for each
data point.
One characteristic function of oxPLs is their ability to
trigger apoptosis (8). One can measure apoptosis signals
by determining the amount of PS, a negatively charged lipid
that is transferred to the outer leaflet of the plasma mem-brane during apoptosis in a variety of cell types (43).
mGFP-GPI-expressing CHO cells were grown in 96-well
microtiter plates and incubated with the same concentra-
tions of POVPC as were used for the TOCCSL experiments.
We used an Annexin V-Cy3 staining kit to detect negatively
charged PS in the plasma membrane 30 min after oxPL in-
cubation. The apoptosis signal increased with increasing
oxPL concentrations (Fig. 4 B), with the strongest change
in the Annexin V-Cy3 signal occurring for POVPC concen-
trations between 0 and 10 mM, and it correlated with nano-
platform disintegration (Fig. 4 C). Measurements obtained
90 min after POVPC incubation yielded similar results,
with a slightly increased Annexin V-Cy3 signal at the mem-
brane (data not shown).Mechanisms of POVPC-induced mGFP-GPI
nanoplatform disintegration
There are two possible scenarios for mGFP-GPI nanoplat-
form disintegration upon incubation with oxPL: 1) a directBiophysical Journal 110(1) 205–213
FIGURE 4 Dose effect of POVPC on mGFP-GPI nanoplatform integrity
and apoptosis signal. CHO cells stably expressing mGFP-GPI were prein-
cubated with different concentrations of POVPC for 20 min. (A) TOCCSL
experiments were carried out at 37C in the presence of POVPC and the
dimer fraction was determined. The dimer fraction a2 decreased monoton-
ically with increasing concentrations of up to 10 mM POVPC and saturated
above this concentration at values close to the detection limit of the
TOCCSL technique. (B) The apoptosis signal of CHO cells was determined
30 min after oxPL incubation by using fluorescently labeled Annexin Vand
determined as a function of POVPC concentration in a plate-reader exper-
iment. (C) The dimer fraction a2 as a function of the Annexin V-Cy3 signal
shows a negative correlation (correlation coefficient R ¼ 0.88).
FIGURE 5 mGFP-GPI nanoplatform disintegration upon addition of
oxPLs depends on aSMase activity. (A) CHO cells stably expressing
mGFP-GPI were incubated with 10 mM POVPC for 20 min, either with
(NB-19þPOVPC) or without (POVPC) preincubation with the aSMase in-
hibitor NB-19 for 30 min at 37C. TOCCSL experiments were carried out at
37C in the presence of POVPC. Nanoplatform integrity could be
conserved by inhibiting the activation of aSMase by preincubation with
NB-19. Incubation with NB-19 alone (NB-19) had no effect on the observed
nanoplatforms. (B) Nanoplatforms were dissolved by incubation with
2 U/mL of COase (COase). Inhibiting aSMase before COase (NB-
19þCOase) treatment did not inhibit nanoplatform disruption, thus point-
ing to a different mechanism for cholesterol-induced disintegration of
mGFP-GPI nanoplatforms.
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membrane leads to their disintegration and 2) an indirect
mechanism involving downstream signaling initiated by
oxPLs induces mGFP-GPI nanoplatform disruption. To
discriminate between the two scenarios, we focused on a
step during apoptosis signaling: the activation of aSMase
(8). To inhibit aSMase activity, we used the inhibitor NB-
19 (7) and preincubated mGFP-GPI-expressing CHO cells
with 10 mM NB-19 for 30 min at 37C. This agent inhibits
aSMase, but not neutral sphingomyelinases, in macro-
phages, and exhibits an IC50 of 8 mM and <2 mM in stimu-
lated macrophages and CHO cells, respectively. With 8 mM
pretreatment (macrophages), the agent reduces minimally
modified LDL-induced apoptosis by 75% (unpublished re-
sults, M. Blaess, University of Jena, and H.-P.D.). After in-
hibition, the cells were treated with 10 mM POVPC forBiophysical Journal 110(1) 205–21320 min and TOCCSL experiments were performed. Bright-
ness analysis revealed an mGFP-GPI dimer fraction of
31% 5 4% (Fig. 5 A), which is nearly identical to the
observed dimer fraction without the presence of oxPL. To
test for a potential direct influence of NB-19 on mGFP-
GPI nanoplatforms, we incubated cells with NB-19 alone.
Analysis yielded nearly the same dimer fraction (30% 5
3%) as for the control (31% 5 3%). Thus, inhibition of
aSMase completely abolished the effect of POVPC, and
obviously the effect of oxPL on mGFP-GPI nanoplatform
disintegration is strongly coupled to aSMase activity.
Finally, we were interested in finding out whether the
standard test for raft-type interactions, namely, their depen-
dence on plasma membrane cholesterol (20,33), could also
be linked to aSMase activity. We thus performed TOCCSL
experiments 20 min after addition of 2 U/mL COase at
37C. A clear decrease in the mGFP-GPI dimer fraction
down to 13% 5 4% was observed (Fig. 5 B). In contrast
to POVPC experiments, a 30 min preincubation with NB-
19 before COase treatment did not significantly influence
the COase-induced reduction of the dimer fraction
(10% 5 3%). We conclude that the mechanism for
mGFP-GPI nanoplatform disintegration upon COase treat-
ment does not involve aSMase activity.DISCUSSION
Nanoplatforms containing GPI-anchored proteins are
considered to be fundamental structural and functional units
of the cell membrane (25). For example, oligomerization of
a GPI protein was found to determine its sorting in polarized
epithelial cells (19), and cross-linking of GPI proteins via
antibodies is known to activate T cells (44,45). The Kusumi
oxPL Disrupt mGFP-GPI Nanoplatforms 211lab provided a detailed molecular picture of the recruitment
of kinases to cross-linked GPI proteins and the subsequent
initiation of downstream signaling events (18,46,47). Inter-
estingly, cholesterol depletion abrogated both Lyn activation
and the transient immobilization of the GPI-protein clusters
(47), which was taken as an indication that cholesterol-
based raft domains control the recruitment of cytosolic
signaling proteins to GPI proteins. In a follow-up study,
Suzuki et al. (18) found that both cholesterol-dependent
raft-type interactions and ectodomain binding contribute
to the association of GPI-anchored proteins. Apparently,
nanoplatform integrity is critical for the initiation of
signaling events via GPI proteins. Notably, most reported in-
terventions that led to nanoplatform formation were induced
by artificial agents, and only a couple of physiological stim-
uli were proven to trigger similar effects. Here, we ad-
dressed the question of how short-chain oxPLs (which are
typically present in oxidatively modified LDL) affect nano-
platforms that host GPI-anchored proteins. We added oxPLs
to an extent that reflects pathophysiological conditions, e.g.,
as found in carotid artery plaque samples (48). Our readout
parameter was the homo-association of mGFP-GPI to stable
nanoplatforms diffusing in the plasma membrane of live
CHO cells (20). Upon addition of POVPC or PGPC, we
found nearly complete disintegration of the mGFP-GPI
nanoplatforms (Figs. 1 F and 2).
Given their rather unique shape, it would not be surprising
to find that oxPLs have a strong impact on their environment
in the plasma membrane, particularly on the distribution of
cholesterol. In general, the mixing of lipids with cholesterol
can be understood by means of the umbrella model, which
assumes that the small polar head of cholesterol cannot
directly cover the nonpolar steroid ring body, and therefore
cholesterol relies on other phospholipids within the bilayer
to cover its headgroup and enable integration (49). The um-
brella effect becomes stronger for inverted-cone-shaped
lipids such as oxPL and Lyso-PC, which provide an addi-
tional shielding area to cover the cholesterol. Indeed, recent
MD simulations and dynamic light-scattering experiments
showed pairing of oxPL species with cholesterol, similar
to mixtures of lysolipid and cholesterol (13). Stefl et al.
(14) also found that cholesterol stabilizes phospholipid
model membranes containing oxPL by filling the void space
caused by the truncated carbonyl chain. They even ascribed
a healing role to cholesterol in the presence of oxidative
damage. Along these lines, we could envision a scenario
in which cholesterol preferentially associates with oxPL,
thereby reducing the pool of freely diffusing cholesterol in
the membrane, and ultimately causing an effect similar to
that observed with cholesterol extraction. To test this hy-
pothesis, we used a similarly inverted cone-shaped lysolipid
instead of oxPL in our experiments. However, application of
Lyso-PC did not lead to disintegration of the mGFP-GPI
nanoplatforms (Fig. 2). Instead, we observed a minor in-
crease in the dimer fraction, which may well have beencaused by interexperiment variability due to slightly varying
experimental and analytical conditions.
Several observations helped us to finally identify the
mode of action of oxPL on plasma membrane nanoplat-
forms: 1) when we varied the POVPC concentration, we
found a pronounced dose dependence of mGFP-GPI nano-
platform disintegration, which correlated with the onset of
apoptosis probed with the specific marker Annexin V-Cy3,
and 2) when we inhibited aSMase activity with NB-19
before addition of POVPC, we found that mGFP-GPI nano-
platforms remained stable in the plasma membrane and
apoptosis was prevented (7). In other words, the mere pres-
ence of oxPL in the plasma membrane did not have any ef-
fect on the integrity of plasma membrane nanoplatforms. In
fact, oxPL action was dependent on aSMase activity, which
induces the generation of ceramide from sphingomyelin. A
well-known functional consequence of ceramide production
is the induction of apoptosis (reviewed in Mathias et al.
(50)). In a previous study, Stemmer et al. (7) also detected
surface exposure of PS in oxPL-treated RAW264.7 and
bone-marrow-derived macrophages. This phenomenon
could be causally related to the activation of aSMase
because inhibition of this enzyme abolished the effect. In
this study, we provide evidence that disintegration of the
mGFP-GPI nanoplatform can also be prevented by inhibi-
tion of aSMase. Thus, the release of GPI-anchored protein
homo-association is not directly mediated by the presence
of POVPC in the plasma membrane; rather, it is a conse-
quence of a process downstream of the initial POVPC-mem-
brane interaction.
In addition, studies have reported that the membrane
(nano-)structure is influenced by the presence of ceramide.
In live cells, Lenne et al. (33) found a reduction in GFP-
GPI confinement to microdomains upon treatment of cells
with exogenously applied sphingomyelinase, and in model
membranes, ceramide was shown to displace cholesterol
from sphingomyelin-cholesterol domains (51,52). More-
over, ceramide forms distinct membrane domains (so-called
ceramide-enriched membrane domains) that cluster and
reorganize signaling molecules (reviewed in Grassme´
et al. (53) and Zhang et al. (54)). In this study, we speculated
that ceramide could directly cause mGFP-GPI nanoplatform
disintegration. However, a more indirect mechanism due to
a change in the plasma membrane cholesterol level upon
aSMase activity also seems possible. Slotte et al. (55)
showed that the degradation of plasma membrane sphingo-
myelin leads to redistribution of cholesterol, with less
cholesterol in the plasma membrane and more in intracel-
lular membranes. This loss of plasma membrane cholesterol
could also cause our observed disintegration of mGFP-GPI.
Phenomenologically, these observations show similarities
to our previous data that revealed disintegration of mGFP-
GPI nanoplatforms upon treatment of CHO cells with COase
(20),which is in linewithmultiple other studies on the choles-
terol dependence of confinement and homodimerization ofBiophysical Journal 110(1) 205–213
212 Brameshuber et al.GPI-anchored proteins (18,33,46,47,56). Interestingly,
cholesterol-induced nanoplatform disintegration did not
involve the action of aSMase (Fig. 5 B). Thus, it may well
be that the two treatments have different modes of action,
which happened to yield similar outcomes.
In summary, we have reported that oxPLs modified with
aldehyde or carboxylic groups at the truncated chain disrupt
plasma membrane nanoplatforms. In the case of aldehyde-
modified oxPLs, we could link the disintegration to the
activation of aSMase. The results are particularly interesting
in view of the pathophysiological relevance of oxPLs in
atherosclerosis and other inflammatory diseases: any
signaling process that involves GPI proteins will be severely
affected by the presence of oxPLs, which diminish the raft-
type associations of these proteins.SUPPORTING MATERIAL
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